Status:
COMPLETED
SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
Asahi Intecc USA Inc
Conditions:
Occlusive Stroke
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to obtain post market data on the Asahi Chikai Black 18 neurovascular guidewire in the treatment of intracranial large vessel occlusive stroke. This will be compared to ...
Detailed Description
This is a prospective registry collecting information on 50 patients treated with the ASAHI Chikai Black 18 microguidewire. Patients will undergo mechanical thrombectomy for acute large vessel occlusi...
Eligibility Criteria
Inclusion
- Male or female patients presenting with acute anterior cerebral circulation large vessel occlusive stroke
- ASPECT score 5 or better
- Occlusion of the ICA terminus and M1 MCA
- Favorable CT perfusion with clinical/radiologic mismatch
- Last known well out to 24 hours
- Age limit \>18 years
- Baseline mRS 0-3
Exclusion
- Intracranial hemorrhage
- ASPECTS (Alberta stroke program early CT score) \<5
- Unfavorable CT perfusion
- Baseline mRS 4 or greater
- Large vessel occlusive stroke with tandem lesion of the cervical internal carotid artery or posterior circulation
Key Trial Info
Start Date :
March 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03438565
Start Date
March 18 2018
End Date
February 1 2020
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029